Ovarian hyperstimulation after the sole use of a gonadotrophin-releasing hormone agonist (Nafarelin) as a complication of in vitro fertilisation treatment.
Brett
S
S
Assisted Conception Unit, Simpsons Memorial Maternity Pavilion, Royal Infirmary of Edinburgh, Scotland, United Kingdom.
Yong
P Y
PY
Thong
K J
KJ
D000328:Adult; D005260:Female; D005307:Fertilization in Vitro; D007987:Gonadotropin-Releasing Hormone / Q000819:agonists*; D006801:Humans; D007049:Iatrogenic Disease; D017274:Nafarelin / Q000009:adverse effects*; D016471:Ovarian Hyperstimulation Syndrome / Q000139:chemically induced* / Q000517:prevention & control; D010053:Ovary / Q000187:drug effects; D010062:Ovulation Induction
D017274:Nafarelin; D007987:Gonadotropin-Releasing Hormone